fda approves first oral glp-1 obesity drug august 1 2025 FDA Approves First GLP-1 Weight

Allulose offers the sweetness of fructose yet is metabolically distinct

This artificial sweetener may negatively impact the gut microbiome, though research is mixed

infusion of liraglutide inhibits eating in rats by directly activating hypothalamic Pomc/Cart neurons in the ARC, without activating GLP-1-producing neurons in the hindbrain, and independent of GLP-1R signaling in vagal afferents, the area postrema (AP) and the PVN [686]

Ganamurali et al

reported that exendin-4 attenuates albuminuria and glomerulosclerosis independent of the glucose-lowering effect in STZ-induced diabetic rats by inhibiting oxidative stress and NF-B activation